DANA STROME: Open Payments
NPI 1790728665 · SAN FRANCISCO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,163 in 33 payments from 11 companies in 2025. Trend: 2023 $63 · 2024 $0 · 2025 $1,163
Food & beverage: $1,163
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $247 |
| PFIZER INC. | 5 | $209 |
| Gilead Sciences, Inc. | 6 | $201 |
| AstraZeneca Pharmaceuticals LP | 1 | $138 |
| Merck Sharp & Dohme LLC | 5 | $137 |
| ViiV Healthcare Company | 3 | $68 |
| Indivior Inc. | 3 | $56 |
| Braeburn Inc. | 2 | $39 |
| SANOFI PASTEUR INC. | 1 | $26 |
| Lilly USA, LLC | 1 | $23 |
Products named: NURTEC ODT, Ozempic, TEZSPIRE, PIFELTRO, Yeztugo, Rybelsus, SUBLOCADE, APRETUDE.
Industry payments across CA — which companies pay providers there.
